Tufts Medical Center
South Building, 6th Floor
800 Washington St.
Boston, MA 02111
Phone #: 617-636-7010
Fax #: 617-636-8525
2017, "Top Doctor," Boston Magazine
2013, "Top Doctor," Boston Magazine
2012, "Top Doctor," Boston Magazine
2012, "Top Doctor," U.S. News & World Report
2011, Fellow, Infectious Diseases Society of America
2008, Fellow, American College of Physicians
1998, Edward H. Kass Award for Clinical Excellence
1997, Defriez Award for Clinical Teaching and Administrative Leadership
1996, James L. Tullis M.D. Award for Intellectual Achievement
1993, Alpha Omega Alpha National Honor Society American Medical Women's Association Award
1. Fowler V.G., K.B. Allen, E.D. Moreira, M. Moustafa, F. Isgro, H.W. Boucher, R. Corey, Y. Carmeli, R. Betts, J.S. Hartzel, N.A. Kartsonis, D. Guris, M.J. DiNubile, M.T. Onorato, and A. Sobanjo-ter Meulen. Effect of an Investigational Vaccine for Preventing Staphylococcus aureus Infections After Cardiothoracic Surgery: A Randomized Trial. JAMA. 2013; 309(13):1368-1378. doi:10.1001/jama.2013.3010.
2. Weston, A., H.W. Boucher. Early High-Dose Daptomycin for MRSA Bloodstream Infections with Elevated Vanomcycin MICs: Ready for Prime Time? Clinical Infectious Diseases 2013; 56(11):1570–2. doi: 10.1093/cid/cit118.
3. Boucher, H.W., G.H. Talbot, D.K. Benjamin, J. Bradley, R.J. Guidos, R.N. Jones, B.E. Murray, R.A. Bonomo, and D. Gilbert. 10 x ‘20 Progress: Development of New Drugs Active against Gram-negative Bacilli - An Update from the Infectious Diseases Society of America. Clinical Infectious Diseases 2013. Jun; 56(12):1685-94. doi: 10.1093/cid/cit152.
4. Johnson, K, H.W. Boucher. Imminent Challenges: Carbapenem-resistant Enterobacteriaceae in Transplant Recipients and Patients with Hematologic Malignancy. Clinical Infectious Diseases 2014. doi: 10.1093/cid/ciu056
5. Doron, S, H.W. Boucher. The Department of Defense Fights the Battle Against Antimicrobial Resistance: Can the United States win the War? Clinical Infectious Diseases 2014. doi: ciu320.
6. Boucher, H.W., M. Wilcox, G.H. Talbot, S. Puttagunta, A.F. Das, M.D. Dunne. Once-Weekly Dalbavancin versus Daily Conventional Therapy for Skin Infection. New England Journal of Medicine 2014; 370: 2169-2179. (Lead article for June 5 edition). doi: 0.1056/NEJMoa1310480.
7. Gilbert, D.N., R.J. Guidos, H.W. Boucher, et al. The 10 x ’20 Initiative: Pursuing a Global Commitment to Develop 10 New Antibacterial Drugs by 2020. Clinical Infectious Diseases 2010; 50: 1081-3.
8. Boucher H.W. Challenges in Anti-Infective Development in the Era of Bad Bugs, No Drugs: A Regulatory Perspective Using the Example of Bloodstream Infection as an Indication. Clinical Infectious Diseases 2010; 50 (Suppl 1): S4–S9.
9. Kanafani, Z. A., W.M. Kourany, V.G. Fowler, D. P. Levine, G.A. Vigliani, M. Campion, D. E. Katz, G.R. Corey, and H.W. Boucher. Clinical Characteristics and Outcomes of Diabetic Patients with Staphylococcus aureus Bacteremia and Endocarditis. European Journal of Clinical Microbiology and Infectious Diseases 2009; 28 (12): 1477-82.
10. Stryjewski, M.E., H.W. Boucher. Gram-negative Bloodstream Infections. International Journal of Antimicrobial Agents 2009; 345: S18-S22
Helen Boucher is Director of the Infectious Diseases Fellowship Program at Tufts Medical Center and Professor of Medicine at Tufts University School of Medicine.
Dr. Boucher’s clinical interests include infections in immunocompromised patients and S. aureus infections. Her research interests focus on S. aureus and the development of new anti-infective agents. She is the author or coauthor of numerous abstracts, chapters and peer-reviewed articles, which have been published in such journals as The New England Journal of Medicine, Antimicrobial Agents and Chemotherapy, Clinical Infectious Diseases, and The Annals of Internal Medicine
she is Associate Editor of Antimicrobial Agents and Chemotherapy.
She has been included in Best Doctors in America since 2009. In 2011, Dr. Boucher was elected Fellow and Member of the Board of Directors of the Infectious Diseases Society of America. In 2012, she was elected to the American Board of Internal Medicine Infectious Disease Exam Writing Committee and in 2014, to the American Board of Internal Medicine Infectious Diseases Subspecialty Board.
In 2015 she was appointed to the Presidential Advisory Council on Combating Antibiotic-resistant Bacteria, and elected Treasurer of the Infectious Diseases Society of America. She was awarded the IDSA Society Citation Award in October, 2015. Dr. Boucher serves on the Board of Trustees of the Physicians of Tufts Medical Center and The College of the Holy Cross.
Member, Board of Directors, Infectious Diseases Society of America
Steering Committee, Mycoses Study Group
Research Committee, Infectious Diseases Society of America
Antimicrobial Availability Task Force, Infectious Diseases Society of America
Graduate Medical Committee, Tufts Medical Center
Infectious Diseases Society of America
American Society of Microbiology
Massachusetts Infectious Diseases Society
American College of Physicians
Massachusetts Medical Society
American Medical Association